S&P 500
(0.13%) 5 187.29 points
Dow Jones
(0.30%) 38 969 points
Nasdaq
(-0.14%) 16 327 points
Oil
(-0.68%) $77.95
Gas
(0.82%) $2.21
Gold
(-0.07%) $2 329.60
Silver
(0.21%) $27.67
Platinum
(2.47%) $988.70
USD/EUR
(-0.03%) $0.928
USD/NOK
(0.47%) $10.88
USD/GBP
(0.06%) $0.796
USD/RUB
(0.18%) $91.51

Actualizaciones en tiempo real para Indivior PLC [INDV.L]

Bolsa: LSE Industria: Pharmaceuticals, Biotechnology & Life Sciences
Última actualización7 may 2024 @ 10:10

0.77% £ 1 446.00

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 10:10):

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders...

Stats
Volumen de hoy 137 294
Volumen promedio 511 646
Capitalización de mercado 1.96B
EPS £0 ( 2024-04-24 )
Próxima fecha de ganancias ( £0 ) 2024-07-25
Last Dividend £36.50 ( 2016-06-16 )
Next Dividend £0 ( N/A )
P/E 1 446.00
ATR14 £1.191 (0.08%)

Volumen Correlación

Largo: 0.27 (neutral)
Corto: 0.39 (neutral)
Signal:(46.837) Neutral

Indivior PLC Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Indivior PLC Correlación - Moneda/Commodity

The country flag 0.48
( neutral )
The country flag 0.40
( neutral )
The country flag -0.60
( weak negative )
The country flag 0.71
( moderate )
The country flag 0.48
( neutral )
The country flag -0.61
( weak negative )

Indivior PLC Finanzas

Annual 2023
Ingresos: £1.09B
Beneficio Bruto: £907.00M (82.98 %)
EPS: £0.0100
FY 2023
Ingresos: £1.09B
Beneficio Bruto: £907.00M (82.98 %)
EPS: £0.0100
FY 2022
Ingresos: £901.00M
Beneficio Bruto: £742.00M (82.35 %)
EPS: £-0.380
FY 2021
Ingresos: £791.00M
Beneficio Bruto: £664.00M (83.94 %)
EPS: £1.410

Financial Reports:

No articles found.

Indivior PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Indivior PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.48%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend £10.40 2015-09-17
Last Dividend £36.50 2016-06-16
Next Dividend £0 N/A
Payout Date 2016-07-29
Next Payout Date N/A
# dividends 2 --
Total Paid Out £46.90 --
Avg. Dividend % Per Year 0.00% --
Score 1.12 --
Div. Sustainability Score 4.95
Div.Growth Potential Score 0
Div. Directional Score 1.992 --
Next Divdend (Est)
(2024-07-15)
£0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.12
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SHOE.L Dividend Knight 2023-07-13 Annually 10 2.57%
IHG.L Dividend Knight 2023-08-31 Annually 21 1.16%
BMY.L Dividend Knight 2023-07-27 Annually 30 1.76%
OCN.L Dividend Knight 2023-05-18 Annually 19 3.96%
EPWN.L Dividend Knight 2023-09-28 Annually 11 2.16%
STM.L Dividend Knight 2023-08-31 Semi-Annually 17 2.49%
JLEN.L Dividend King 2023-08-31 Quarterly 11 366.93%
CAM.L Dividend Junior 2023-09-14 Annually 32 1.66%
PSHD.L No Dividend Player 2023-08-17 Annually 6 0.41%
GBG.L Dividend Junior 2023-06-22 Annually 22 0.51%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.001831.5009.9610.00[0 - 0.5]
returnOnAssetsTTM0.001021.2009.9710.00[0 - 0.3]
returnOnEquityTTM0.005421.500-1.051-1.576[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.9680.800-0.161-0.129[1 - 3]
quickRatioTTM0.5260.800-1.609-1.287[0.8 - 2.5]
cashRatioTTM0.2421.5009.7710.00[0.2 - 2]
debtRatioTTM0.144-1.5007.59-10.00[0 - 0.6]
interestCoverageTTM0.5531.000-0.906-0.906[3 - 30]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
freeCashFlowPerShareTTM-2.682.00-1.339-2.68[0 - 20]
debtEquityRatioTTM0.215-1.5009.14-10.00[0 - 2.5]
grossProfitMarginTTM0.8301.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.01921.000-1.616-1.616[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.1171.000-7.32-7.32[0.2 - 2]
assetTurnoverTTM0.5590.8009.607.68[0.5 - 2]
Total Score4.95

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM1 238.721.00010.000[1 - 100]
returnOnEquityTTM0.005422.50-0.676-1.576[0.1 - 1.5]
freeCashFlowPerShareTTM-2.682.00-0.892-2.68[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.2881.000-9.700[0.1 - 0.5]
Total Score-0.971

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico